Anti-AFP antibody produced in rabbit
SIGMA/HPA010607 - Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Synonym: Anti-α-1-Fetoprotein antibody produced in rabbit; Anti-α-Fetoglobulin antibody produced in rabbit; Anti-α-Fetoprotein precursor antibody produced in rabbit
MDL Number: MFCD01092266
Product Type: Chemical
antibody form | affinity isolated antibody |
antibody product type | primary antibodies |
application(s) | research pathology |
biological source | rabbit |
clone | polyclonal |
conjugate | unconjugated |
enhanced validation | recombinant expression recombinant expression RNAi knockdown Learn more about Antibody Enhanced Validation |
form | buffered aqueous glycerol solution |
immunogen sequence | FAQFVQEATYKEVSKMVKDALTAIE |
packaging | antibody small pack of 25 μL |
product line | Prestige Antibodies® Powered by Atlas Antibodies |
Quality Level | 100 |
shipped in | wet ice |
species reactivity | human |
storage temp. | −20°C |
technique(s) | immunoblotting: 0.04-0.4 μg/mL |
immunohistochemistry: 1:200-1:500 | |
UniProt accession no. | P02771 |
Application: | Anti-AFP antibody produced in rabbit, a Prestige Antibody, is developed and validated by the Human Protein Atlas (HPA) project . Each antibody is tested by immunohistochemistry against hundreds of normal and disease tissues. These images can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. The antibodies are also tested using immunofluorescence and western blotting. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige . |
Biochem/physiol Actions: | AFP (α fetoprotein) levels decrease by the second year of birth and its ectopic expression is linked with tumors, such as hepatobastoma, hepatocellular carcinoma (HCC) and yolk sac tumors. Maximum AFP-expressing tumors are of stomach, bile duct or pancreatic origin. AFP-expressing rectal cancer is extremely rare and is usually metastasized to liver with poor prognosis. In patients with chronic hepatitis C, high levels of this protein are linked with increased risk of developing HCC. In patients with metastatic gastric cancer (GC), follow-up of AFP concentrations can help determine early treatment response. For early and intermediate stages of HCC, the addition of this protein and ascites in the BCLC Barcelona Clinic Liver Cancer (BCLC) staging can improvise prognosis determination. |
Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
Features and Benefits: | Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section. Every Prestige Antibody is tested in the following ways: • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues. • Protein array of 364 human recombinant protein fragments. |
General description: | AFP (α fetoprotein) is a 70kDa serum glycoprotein, and is produced during gestation from fetal liver and yolk sac. |
Immunogen: | α-Fetoprotein precursor recombinant protein epitope signature tag (PrEST) |
Legal Information: | Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC |
Linkage: | Corresponding Antigen APREST86803 . |
Physical form: | Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 1 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | −20°C |
UNSPSC | 12352203 |